Research progress of sepsis complicated with capillary leakage syndrome

doi:10.16352/j.issn.1001-6325.2022.07.1144

Abstract

Abstract: Sepsis is a common and fatal disease with high mortality. Sepsis is a life-threatening organ dysfunction caused by abnormal host response to infection. Some patients also complicate with hypo-albuminemia, hypotension, oliguria, edema and other phenomena, namely capillary leakage syndrome (CLS). Sepsis with CLS is a complex disease urgently needs active treatment, but a successful treatment must be based on in-depth understanding of the pathogenesis and combined with clinical treatment experience.

Key words: sepsis, capillary leakage syndrome, pathogenesis, clinical treatment

CLC Number:

R364

LIN Bai-bai, QIAN Feng-hua, QIAN Yi-ming, ZHAO Lei, SUN Qi, CHU Meng-yao, SHEN Meng-wen. Research progress of sepsis complicated with capillary leakage syndrome[J]. Basic & Clinical Medicine, 2022, 42(7): 1144-1147.

References 28

[1]	Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016, 315: 801-810.
[2]	Ma S, Evans RG, Iguchi N, et al. Sepsis-induced acute kidney injury: a disease of the microcirculation[J]. Microcirculation, 2019, 26: e12483. doi: 10.1111/micc.12483.
[3]	Hajare KR, Patil P, Bansode J. Idiopathic systemic capillary leak syndrome[J]. Indian J Crit Care Med, 2018, 22: 369-371.
[4]	Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome: etiologies, pathophysiology, and management[J]. Kidney Int, 2017, 92: 37-46.
[5]	Mertz P, Lebrun-Vignes B, Salem JE, et al. Characteriz-ing drug-induced capillary leak syndromes using the World Health Organization VigiBase[J]. J Allergy Clin Immunol, 2019, 143: 433-436.
[6]	Xie Z, Ghosh CC, Patel R, et al. Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome)[J]. Blood, 2012, 119: 4321-4332.
[7]	Xu D, Liu T, Lin L, et al. Exposure to endosulfan increases endothelial permeability by transcellular and paracellular pathways in relation to cardiovascular diseases[J]. Environ Pollut, 2017, 223: 111-119.
[8]	Takeuchi O, Akira S. Pattern recognition receptors and inflammation[J]. Cell, 2010, 140: 805-820.
[9]	D'Elia RV, Harrison K, Oyston PC, et al. Targeting the “cytokine storm” for therapeutic benefit[J]. Clin Vaccine Immunol, 2013, 20: 319-327.
[10]	Raymond SL, Holden DC, Mira JC, et al. Microbial recognition and danger signals in sepsis and trauma[J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863: 2564-2573.
[11]	Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nat Immunol, 2010, 11: 373-384.
[12]	Akwii RG, Sajib MS, Zahra FT, et al. Role of angiopoietin-2 in vascular physiology and pathophysiology[J]. Cells, 2019, 8: 471.doi:10.3390/cells8050471.
[13]	Druey KM, Parikh SM. Idiopathic systemic capillary leak syndrome (Clarkson disease)[J]. J Allergy Clin Immunol, 2017, 140: 663-670.
[14]	Geranmayeh MH, Rahbarghazi R, Farhoudi M. Targeting pericytes for neurovascular regeneration[J]. Cell Commun Signal, 2019, 17: 26. doi: 10.1186/s12964-019-0340-8.
[15]	Claesson-Welsh L. Vascular permeability--the essentials[J]. Ups J Med Sci, 2015, 120:135-143.
[16]	王永玲, 李冬霞, 高建芝, 等.VEGF在肥胖患者乳腺癌组织中的表达及临床意义[J].基础医学与临床, 2012, 32: 544-547.
[17]	Li X, Padhan N, Sjöström EO, et al. VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread[J]. Nat Commun, 2016, 7: 11017. doi:10.1038/ncomms11017.
[18]	Heinolainen K, Karaman S, D'Amico G, et al. VEGFR3 modulates vascular permeability by controlling VEGF/VEGFR2 signaling[J]. Circ Res, 2017, 120: 1414-1425.
[19]	Regula JT, Lundh von Leithner P, Foxton R, et al. Targeting key angiogenic pathways with a bispecific cross-MAb optimized for neovascular eye diseases[J]. EMBO Mol Med, 2016, 8: 1265-1288.
[20]	许小泽, 刘雪燕, 郑标林, 等. 脓毒症毛细血管渗漏综合征的机制及临床治疗探究[J].当代医学, 2020, 26: 189-191.
[21]	黄增相, 何超, 陶骅, 等. 肠源性脓毒症并发肺毛细血管渗漏综合征一例救治[J].中国呼吸与危重监护杂志, 2015, 14: 98-100.
[22]	王晓锋, 瞿金龙. 乌司他丁治疗急性呼吸窘迫综合征的临床研究[J].交通医学, 2019, 33: 574-576.
[23]	陈豆豆, 常青, 章向成, 等. 连续性肾脏替代治疗对严重脓毒症患者肾功能及微循环的影响[J]. 广西医科大学学报, 2017, 34: 851-854.
[24]	Das M, Karnam A, Stephen-Victor E, et al. Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy[J]. Cell Death Dis,2020,11: 50. doi: 10.1038/s41419-020-2249-y.
[25]	贺周香. 免疫球蛋白对脓毒症患者血管内皮功能的影响[J].中外医学研究, 2019, 17: 52-53.
[26]	Liu S, Yao C, Zhang J, et al. Efficacy of Xuebijing Injection for sepsis (EXIT-SEP): protocol for a randomised controlled trial[J]. BMJ Open, 2019, 9: e028664. doi: 10.1136/bmjopen-2018-028664.
[27]	张利鹏, 张立彦, 王雪芳, 等. 血必净联合西医治疗老年毛细血管渗漏综合征的疗效及对血压、血清炎症因子的影响[J].实用老年医学, 2017, 31: 462-465.
[28]	Chen G, Gao Y, Jiang Y, et al. Efficacy and safety of xuebijing injection combined with ulinastatin as adjunctive therapy on sepsis: a systematic review and meta-analysis[J]. Front Pharmacol, 2018, 9: 743. doi: 10.3389/fphar.2018.00743.